GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Medicus Sciences Acquisition Corp (NAS:MSAC) » Definitions » Debt-to-Asset

Medicus Sciences Acquisition (Medicus Sciences Acquisition) Debt-to-Asset : 0.00 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Medicus Sciences Acquisition Debt-to-Asset?

Medicus Sciences Acquisition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.00 Mil. Medicus Sciences Acquisition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.00 Mil. Medicus Sciences Acquisition's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2022 was $93.43 Mil. Medicus Sciences Acquisition's debt to asset for the quarter that ended in Sep. 2022 was 0.00.


Medicus Sciences Acquisition Debt-to-Asset Historical Data

The historical data trend for Medicus Sciences Acquisition's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Sciences Acquisition Debt-to-Asset Chart

Medicus Sciences Acquisition Annual Data
Trend Dec20 Dec21
Debt-to-Asset
0.65 -

Medicus Sciences Acquisition Quarterly Data
Nov20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-Asset Get a 7-Day Free Trial - - - - -

Competitive Comparison of Medicus Sciences Acquisition's Debt-to-Asset

For the Shell Companies subindustry, Medicus Sciences Acquisition's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicus Sciences Acquisition's Debt-to-Asset Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Medicus Sciences Acquisition's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Medicus Sciences Acquisition's Debt-to-Asset falls into.



Medicus Sciences Acquisition Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Medicus Sciences Acquisition's Debt-to-Asset for the fiscal year that ended in Dec. 2021 is calculated as

Medicus Sciences Acquisition's Debt-to-Asset for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicus Sciences Acquisition  (NAS:MSAC) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Medicus Sciences Acquisition Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Medicus Sciences Acquisition's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicus Sciences Acquisition (Medicus Sciences Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
152 West 57th Street, Floor 20, New York, NY, USA, 10019
Medicus Sciences Acquisition Corp is a blank check company.
Executives
Eric Cheng officer: Chief Business Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Kenneth Berkovitz director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Christopher Kaster director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Ross Levine director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Judah Drillick officer: Chief Financial Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Jacob Gottlieb director, 10 percent owner, officer: Executive Chairman 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Medicus Sciences Holdings Llc 10 percent owner 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Michael Castor director, 10 percent owner, officer: Chief Executive Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019

Medicus Sciences Acquisition (Medicus Sciences Acquisition) Headlines